Related Experiment Video
Updated: Jun 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
'Conditioning' the heart during surgery
Vinod Venugopal1, Andrew Ludman, Derek M Yellon
1The Hatter Cardiovascular Institute, University College London Hospital, 67 Chenies Mews, London WC1E 6HX, United Kingdom.
Insights
Coronary heart disease (CHD) is a leading cause of death. This review explores
Area of Science:
- Cardiology and Cardiac Surgery
- Ischaemia-Reperfusion Injury
- Cardioprotection
Background:
- Coronary heart disease (CHD) remains a global health challenge, with Coronary Artery Bypass Graft (CABG) surgery as a primary revascularization treatment.
- Increasingly high-risk patient profiles undergoing CABG are associated with significant morbidity and mortality.
- Myocardial injury from ischaemia-reperfusion during cardiac surgery negatively impacts clinical outcomes.
Purpose of the Study:
- To review novel treatment strategies for myocardial protection during cardiac surgery.
- To explore the potential of 'conditioning' the heart to harness endogenous cardioprotective mechanisms.
- To reduce myocardial injury and preserve left ventricular systolic function in cardiac surgery patients.
Main Methods:
- Review of existing literature on myocardial protection strategies in cardiac surgery.
- Focus on 'conditioning' techniques, including brief ischaemia and pharmacological agents.
- Analysis of endogenous cardioprotective capabilities.
Main Results:
- Myocardial injury during cardiac surgery significantly worsens patient outcomes.
- 'Conditioning' offers a novel approach to mitigate ischaemia-reperfusion injury.
- Harnessing endogenous cardioprotection may improve clinical results.
Conclusions:
- New strategies are essential to protect the heart during cardiac surgery.
- 'Conditioning' presents a promising avenue for reducing myocardial damage and improving outcomes.
- Further research into cardioprotective conditioning is warranted.
Abstract:
Coronary heart disease (CHD) is the leading cause of death worldwide. Coronary artery bypass graft (CABG) surgery remains the procedure of choice for coronary artery revascularisation in a large number of patients with severe CHD. However, the profile of patients undergoing CABG surgery is changing with increasingly higher-risk patients being operated upon, resulting in significant morbidity and mortality in this patient group. Myocardial injury sustained during cardiac surgery, most of which can be attributed to acute myocardial ischaemia-reperfusion injury, is associated with worse short-term and long-term clinical outcomes. Clearly, new treatment strategies are required to protect the heart during cardiac surgery in terms of reducing myocardial injury and preserving left ventricular systolic function, such that clinical outcomes can be improved. 'Conditioning' the heart to harness its endogenous cardioprotective capabilities using either brief ischaemia or pharmacological agents, provides a potentially novel approach to myocardial protection during cardiac surgery, and is the subject of this review article.
More Related Videos
09:10Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
Published on: January 12, 2019
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023